Trials / Recruiting
RecruitingNCT07407816
Feasibility Study of the Supira System in Patients Undergoing HRPCI With Support Beyond the PCI Procedure
Feasibility Study of the Supira System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (HRPCI) Who May Benefit From Mechanical Circulatory Support Beyond the PCI Procedure
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Supira Medical · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the safety and feasibility of the Supira System in heart failure patients with low LVEF, undergoing HRPCI with use of mechanical circulatory support who may benefit from cardiovascular hemodynamic support beyond the PCI procedure.
Detailed description
The study is a prospective, non-randomized, single-arm, multi-center, feasibility study. The Supira System is a minimally invasive, percutaneous ventricular assist device (pVAD) that is intended to provide hemodynamic support to patients undergoing high risk percutaneous coronary intervention (HRPCI) and requiring hemodynamic support. The Catheter is inserted percutaneously, across the aortic valve, and into the left ventricle under fluoroscopic guidance. The left ventricle is unloaded by pumping blood from the ventricle into the ascending aorta and systemic circulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Supira System | The Supira System is a minimally invasive, percutaneous ventricular assist device (pVAD) that is intended to provide hemodynamic support to patients undergoing high risk percutaneous coronary intervention (HRPCI). The Catheter is inserted percutaneously via the femoral artery, across the aortic valve, and into the left ventricle under fluoroscopic guidance. The left ventricle is unloaded by pumping blood from the ventricle into the ascending aorta and systemic circulation. |
Timeline
- Start date
- 2025-10-12
- Primary completion
- 2026-12-01
- Completion
- 2027-05-01
- First posted
- 2026-02-12
- Last updated
- 2026-02-17
Locations
2 sites across 1 country: Georgia
Source: ClinicalTrials.gov record NCT07407816. Inclusion in this directory is not an endorsement.